TORONTO -- (MARKET WIRE) -- December 14, 2006 -- Generex Biotechnology Corporation (NASDAQ: GNBT) announced today that the results of clinical studies on a novel cancer vaccine being developed by its wholly owned immunotherapeutics subsidiary, Antigen Express, Inc., will be presented at the 29th Annual San Antonio Breast Cancer Symposium (www.sabcs.org), December 14 - 17, 2006. The results of the studies will be presented by COL George Peoples, MD, a collaborator of Antigen Express who has been directing the trials at the Walter Reed Army Medical Center.
